Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 13

Therapeutics and Clinical Risk Management


Archive: Volume 13, 2017

Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients

Głażewska EK, Niczyporuk M, Ławicki S, Szmitkowski M, Donejko M, Zajkowska M, Będkowska GE, Przylipiak A

Therapeutics and Clinical Risk Management 2017, 13:575-582

Published Date: 27 April 2017

Positive correlation between environmental PM2.5 and blood lead levels in patients undergoing maintenance hemodialysis

Chen CY, Liu MH, Hsu CW, Weng CH, Yen TH, Huang WH

Therapeutics and Clinical Risk Management 2017, 13:555-564

Published Date: 24 April 2017

The effect of sodium hyaluronate–chondroitin sulfate combined solution on cartilage formation in osteochondral defects of the rabbit knee: an experimental study

Tosun HB, Gürger M, Gümüştaş SA, Uludag A, Üçer Ö, Serbest S, Çelik S

Therapeutics and Clinical Risk Management 2017, 13:523-532

Published Date: 18 April 2017

Patient characteristics associated with false arrhythmia alarms in intensive care

Harris PR, Zègre-Hemsey JK, Schindler D, Bai Y, Pelter MM, Hu X

Therapeutics and Clinical Risk Management 2017, 13:499-513

Published Date: 19 April 2017

Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis

Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M

Therapeutics and Clinical Risk Management 2017, 13:455-468

Published Date: 11 April 2017

Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation

Tarnowski M, Słuczanowska-Głabowska S, Pawlik A, Mazurek-Mochol M, Dembowska E

Therapeutics and Clinical Risk Management 2017, 13:439-446

Published Date: 6 April 2017

Role of pirfenidone in the management of pulmonary fibrosis

Meyer KC, Decker CA

Therapeutics and Clinical Risk Management 2017, 13:427-437

Published Date: 3 April 2017

Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population

Jia LQ, Wang Z, Men J, Cai H, Wei M

Therapeutics and Clinical Risk Management 2017, 13:421-425

Published Date: 31 March 2017

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities

Huri HZ, Ling CF, Razack AH

Therapeutics and Clinical Risk Management 2017, 13:407-419

Published Date: 31 March 2017

Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure

Shammas NW, Shammas GA, Jones-Miller S, Gumpert MR, Gumpert MJ, Harb C, Chammas MZ, Shammas WJ, Khalafallah RA, Barzgari A, Bou Dargham B, Daher GE, Rachwan RJ, Shammas AN

Therapeutics and Clinical Risk Management 2017, 13:401-406

Published Date: 30 March 2017

Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction

Satilmisoglu MH, Ozyilmaz SO, Gul M, Ak Yildirim H, Kayapinar O, Gokturk K, Aksu H, Erkanli K, Eksik A

Therapeutics and Clinical Risk Management 2017, 13:393-400

Published Date: 29 March 2017

Urinary cadmium levels predict mortality of patients with acute heart failure

Hsu CW, Weng CH, Lee CC, Lin-Tan DT, Chu PH, Chen KH, Yen TH, Huang WH

Therapeutics and Clinical Risk Management 2017, 13:379-386

Published Date: 27 March 2017

Effects of sharing information on drug administration errors in pediatric wards: a pre–post intervention study

Chua SS, Choo SM, Sulaiman CZ, Omar A, Thong MK

Therapeutics and Clinical Risk Management 2017, 13:345-353

Published Date: 23 March 2017

Second-line afatinib administration in an elderly patient with squamous cell carcinoma

Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Benhassen N, Sardeli C, Stalikas N, Toitou M, Huang H

Therapeutics and Clinical Risk Management 2017, 13:341-343

Published Date: 20 March 2017

Clinical characteristics of zinc phosphide poisoning in Thailand

Trakulsrichai S, Kosanyawat N, Atiksawedparit P, Sriapha C, Tongpoo A, Udomsubpayakul U, Rittilert P, Wananukul W

Therapeutics and Clinical Risk Management 2017, 13:335-340

Published Date: 14 March 2017

An estimate of the cost of administering intravenous biological agents in Spanish day hospitals

Nolla JM, Martín E, Llamas P, Manero J, Rodríguez de la Serna A, Fernández-Miera MF, Rodríguez M, López JM, Ivanova A, Aragón B

Therapeutics and Clinical Risk Management 2017, 13:325-334

Published Date: 14 March 2017

The risk reduction of recurrent periodontal pathogens of local application minocycline HCl 2% gel, used as an adjunct to scaling and root planing for chronic periodontitis treatment

Soeroso Y, Akase T, Sunarto H, Kemal Y, Salim R, Octavia M, Viandita A, Setiawan J, Bachtiar BM

Therapeutics and Clinical Risk Management 2017, 13:307-314

Published Date: 10 March 2017

Clinical role of brexpiprazole in depression and schizophrenia

Parikh NB, Robinson DM, Clayton AH

Therapeutics and Clinical Risk Management 2017, 13:299-306

Published Date: 10 March 2017

The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation

Rivinius R, Helmschrott M, Ruhparwar A, Erbel C, Gleissner CA, Darche FF, Thomas D, Bruckner T, Katus HA, Doesch AO

Therapeutics and Clinical Risk Management 2017, 13:287-297

Published Date: 8 March 2017

High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma

Na N, Li H, Xu CF, Miao B, Hong LQ, Huang ZY, Jiang Q

Therapeutics and Clinical Risk Management 2017, 13:279-285

Published Date: 27 February 2017

Helicobacter pylori infection is not associated with failure to thrive: a case–control study

Chiu NC, Lin CY, Chi H, Yeung CY, Ting WH, Chan WT, Jiang CB, Li ST, Lin CH, Lee HC

Therapeutics and Clinical Risk Management 2017, 13:273-278

Published Date: 23 February 2017

Psychological factors as risk factors for poor hip function after total hip arthroplasty

Benditz A, Jansen P, Schaible J, Roll C, Grifka J, Götz J

Therapeutics and Clinical Risk Management 2017, 13:237-244

Published Date: 21 February 2017

Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context

Le AD, Alzghari SK, Jean GW, La-Beck NM

Therapeutics and Clinical Risk Management 2017, 13:223-236

Published Date: 21 February 2017

Statin therapy reduces the likelihood of suboptimal blood pressure control among Ugandan adult diabetic patients

Lumu W, Kampiire L, Akabwai GP, Kiggundu DS, Kibirige D

Therapeutics and Clinical Risk Management 2017, 13:215-221

Published Date: 20 February 2017

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor

Manduzio P

Therapeutics and Clinical Risk Management 2017, 13:169-177

Published Date: 13 February 2017

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers

Kamimura M, Uchiyama S, Nakamura Y, Ikegami S, Mukaiyama K, Kato H

Therapeutics and Clinical Risk Management 2017, 13:161-168

Published Date: 13 February 2017

Emergency thoracic ultrasound and clinical risk management

Interrigi MC, Trovato FM, Catalano D, Trovato GM

Therapeutics and Clinical Risk Management 2017, 13:151-160

Published Date: 9 February 2017

Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients

Ali Khan R, Kapur P, Jain A, Farah F, Bhandari U

Therapeutics and Clinical Risk Management 2017, 13:139-149

Published Date: 20 February 2017

Prevalence of metabolic syndrome in adolescents living in Mthatha, South Africa

Sekokotla MA, Goswami N, Sewani-Rusike CR, Iputo JE, Nkeh-Chungag BN

Therapeutics and Clinical Risk Management 2017, 13:131-137

Published Date: 7 February 2017

Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo

Yin L, Zhao C, Han J, Li Z, Zhen Y, Xiao R, Xu Z, Sun Y

Therapeutics and Clinical Risk Management 2017, 13:117-130

Published Date: 7 February 2017

Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis

Chang DH, Mammadov K, Hickethier T, Borggrefe J, Hellmich M, Maintz D, Kabbasch C

Therapeutics and Clinical Risk Management 2017, 13:111-115

Published Date: 24 January 2017

Effects of bariatric surgery on urinary incontinence

Bulbuller N, Habibi M, Yuksel M, Ozener O, Oruc MT, Oner OZ, Kazak MA

Therapeutics and Clinical Risk Management 2017, 13:95-100

Published Date: 19 January 2017

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study

Borba HHL, Wiens A, Steimbach LM, Tonin FS, Pedroso MLA, Ivantes CAP, Fernandez-Llimos F, Pontarolo R

Therapeutics and Clinical Risk Management 2017, 13:59-64

Published Date: 10 January 2017

The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis

Liu YT, Yang PY, Yang YW, Sun HY, Lin IC

Therapeutics and Clinical Risk Management 2017, 13:41-48

Published Date: 6 January 2017

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

Affronti ML, Woodring S, Peters KB, Herndon II JE, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS

Therapeutics and Clinical Risk Management 2017, 13:33-40

Published Date: 23 December 2016

Identification of a new mutation in an Iranian family with hereditary multiple osteochondromas

Akbaroghli S, Balali M, Kamalidehghan B, Saber S, Aryani O, Yong Meng G, Houshmand M

Therapeutics and Clinical Risk Management 2017, 13:15-19

Published Date: 20 December 2016

Diagnostic accuracy of nodular gastritis for H. pylori infection

Romero-Flores JL, Fernandez-Rivero JA, Marroquín-Fabian E, Téllez-Avila FI, Sánchez-Jiménez BA, Juárez-Hernández E, Uribe M, Chávez-Tapia NC

Therapeutics and Clinical Risk Management 2017, 13:9-14

Published Date: 16 December 2016

Urinary tract infections in Romanian patients with diabetes: prevalence, etiology, and risk factors

Chiţă T, Timar B, Muntean D, Bădițoiu L, Horhat F, Hogea E, Moldovan R, Timar R, Licker M

Therapeutics and Clinical Risk Management 2017, 13:1-7

Published Date: 16 December 2016